The conference to summarize of Test Quality Management in 2024

On November 8, 2024, Medlinks Consulting JSC attended the Scientific Conference: "Summary of Test Quality Management in 2024, towards connecting and recognizing test results nationwide in 2025".

On November 8, 2024, MedLinks Consulting Joint Stock Company attended the conference: "Summary of Test Quality Management in 2024, towards connecting and recognizing test results nationwide in 2025" at the Ho Chi Minh City University of Medicine and Pharmacy - 217 Hong Bang, Ward 11, District 5, Ho Chi Minh City.

1. Conference information

The conference is an event that brings together leaders of the Department of Health, Board of Directors and managers of testing departments from hospitals, medical centers and laboratories, along with many experts in the field.

The conference aims to summarize the Center's 2024 testing quality management work, evaluate achievements, challenges and lessons learned. At the same time, create a forum to discuss the implementation of a nationwide test results connection system, promote cooperation between medical units, towards the goal of connection by 2025.

2. Conference content

The conference has the following main contents:

Speech from the leaders of the Ministry of Health, Department of Medical Examination and Treatment Management

Expert reporting session:

• Summary report on Laboratory Quality Management in 2024 - Dr. Le Van Chuong - Deputy Director in charge of the Center
• On-site Laboratory Quality Control (POCT) - Dr. Tran Thanh Vinh, Head of Biochemistry Department - Cho Ray Hospital;
• Clinical value of using reticulocytes - BSCKII. Huynh Thi Bich Huyen - Blood Transfusion and Hematology Hospital, City. Ho Chi Minh
• Principles and applications of allergy and autoimmune testing in clinical practice - Dr. Trinh Hoang Kim Tu, Center for Molecular Biomedicine, University of Medicine and Pharmacy, Ho Chi Minh City
• Immunoassay for blotting paper - Optimal solution for multi-allergen testing
• Remote external control solution for semen analysis system
• Application of vacuum blood collection tubes in improving stability and standardization of test samples

Product/service display

3. MedLinks booth

At the conference, MedLinks Consulting Joint Stock Company introduced the AliveDx's fully automated autoimmune disease solution. This is a combination of the LUMIQ immunofluorescence assay (IFA ANA) and the MOSAIQ 125 autoimmune and allergy assay (ENA & Allergy).

This solution from AliveDx will help many medical facilities automate testing for patients with systemic autoimmune diseases, helping with early diagnosis and optimizing treatment costs. With its novelty and uniqueness, the solution has attracted much attention from medical experts in the field of autoimmune and allergy.

MedLinks Company is honored to participate and accompany the Conference as a sponsor, congratulating the Conference on its great success.

MedLinks Consulting Joint Stock Company is the official distributor of AliveDx's fully automated autoimmune and allergy testing solution in Vietnam. Please contact Hotline 0965 053 050 or send a message via Fanpage Autoimmune Disease if you need more information.